Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2012

Filed with the SEC on Feb 26, 2013 and accepted by EDGAR at Feb 26, 2013, 14:32 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2012-01-01 to 2012-12-31$9.20bnus-gaap:CostOfRevenue
Gross profit12 months2012-01-01 to 2012-12-31$4.60bnus-gaap:GrossProfit
Research and development12 months2012-01-01 to 2012-12-31$111.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2012-01-01 to 2012-12-31$2.22bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2012-01-01 to 2012-12-31$2.22bnus-gaap:OperatingIncomeLoss
Interest expense12 months2012-01-01 to 2012-12-31$470.5mus-gaap:InterestExpense
Income tax12 months2012-01-01 to 2012-12-31$605.1mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2012-01-01 to 2012-12-31$1.19bnus-gaap:NetIncomeLoss
Diluted shares (weighted)12 months2012-01-01 to 2012-12-31302,900,716 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2012-01-01 to 2012-12-31$2.04bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2012-01-01 to 2012-12-31$675.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2012-01-01 to 2012-12-31$271.7mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2012-12-31$688.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-12-31$6.13bnus-gaap:AssetsCurrent
Total assetsAt period end2012-12-31$22.33bnus-gaap:Assets
Current liabilitiesAt period end2012-12-31$3.17bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-12-31$12.60bnus-gaap:Liabilities
Long-term debtAt period end2012-12-31$7.84bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2012-12-31$121.8mus-gaap:DebtCurrent
Short-term borrowingsAt period end2012-12-31$117.8mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2012-12-31$8.94bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-13-001694. Last ingested by Listed: Nov 14, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.